Coronary artery disease (CAD) is the most Common type of heart disease, also referred to as coronary heart disorder. Coronary arteries are the essential blood vessels that supply your heart with blood, oxygen and nutrients. CAD occurs when these that provide blood to coronary heart muscle turn out to be hardened and narrowed. Atherosclerosis (regularly known as “hardening” or “clogging” of the arteries) is the buildup of cholesterol and fatty deposits (referred to as plaques) on the internal walls of the arteries. These plaques can avert blood go with the flow to the center muscle by clogging the artery or via causing abnormal artery tone and function.
Out of the 16 million deaths under the age of 70 due to non-communicable diseases, 82% are in low and middle income countries and 37% are caused by CVDs. According to the latest WHO data published in May 2014 Coronary Heart Disease Deaths in France reached 39,931 or 9.66% of total deaths. The age adjusted Death Rate is 29.97 per 100,000 of population ranks France 171 in the world.
Treatment for CAD involves lifestyle changes, if necessary, drugs and certain medical procedures. Various drugs that are used to treat CAD are Cholesterol-modifying medications, Beta blockers, Nitroglycerin, Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). Some of the Procedures to restore and improve blood flow like Angioplasty and stent placement (percutaneous coronary revascularization), Coronary artery bypass surgery.
Some of the Major researches on Coronary artery disease in France are Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients with Stable Coronary Artery Disease, Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.